129 filings
Page 4 of 7
8-K
79myy2s1
11 Jun 21
Submission of Matters to a Vote of Security Holders
4:10pm
S-3ASR
de52vs3w
10 Jun 21
Automatic shelf registration
7:03am
8-K
rm36my
24 May 21
Departure of Directors or Certain Officers
4:10pm
8-K
gk894jrwtm4segsif
11 May 21
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
7:48am
DEFA14A
c0vm 34u7khgaa
23 Apr 21
Additional proxy soliciting materials
4:15pm
8-K
sw61oy5
23 Apr 21
Departure of Directors or Certain Officers
4:10pm
DEF 14A
iys4l6 ly00gs7nzim
23 Apr 21
Definitive proxy
4:05pm
424B5
npv4 3opk05kmdtct
1 Apr 21
Prospectus supplement for primary offering
8:15am
8-K
2wmrn suabas08lnp5
1 Apr 21
Other Events
7:48am
424B7
v5prsatfljw
1 Apr 21
Prospectus with selling stockholder info
7:36am
424B7
mus8ele 5vuuvj2z4
1 Apr 21
Prospectus with selling stockholder info
7:24am
S-3ASR
nv60p3sxr
1 Apr 21
Automatic shelf registration
6:08am
S-8
6d6g34rjw392o lmx
17 Mar 21
Registration of securities for employees
7:15am
8-K
dy8ylm0n
15 Mar 21
Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results
6:45am
8-K
qzauqvvto38nnai7g
23 Feb 21
Beam Therapeutics Announces Acquisition of Guide Therapeutics
8:43am
8-K
zgf3pdf
19 Jan 21
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
6:46am
8-K
4heoltvy9bltw
13 Jan 21
Regulation FD Disclosure
12:00am
8-K
1trf1
12 Jan 21
Regulation FD Disclosure
7:00am